163 related articles for article (PubMed ID: 8804809)
1. Selective prescribing of third generation oral contraceptives (OCs).
Jamin C; de Mouzon J
Contraception; 1996 Jul; 54(1):55-6. PubMed ID: 8804809
[TBL] [Abstract][Full Text] [Related]
2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
3. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
4. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
[TBL] [Abstract][Full Text] [Related]
5. 2 methods for prescribing third-generation OCs.
Contracept Technol Update; 1997 Dec; 18(12):148-9. PubMed ID: 12348220
[TBL] [Abstract][Full Text] [Related]
6. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
[TBL] [Abstract][Full Text] [Related]
8. The 1995 pill scare revisited: anatomy of a non-epidemic.
Spitzer WO
Hum Reprod; 1997 Nov; 12(11):2347-57. PubMed ID: 9436662
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making?
Westhoff CL
Contraception; 1996 Jul; 54(1):1-3. PubMed ID: 8804800
[TBL] [Abstract][Full Text] [Related]
10. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
13. The risk of venous thromboembolism in users of postcoital contraceptive pills.
Vasilakis C; Jick SS; Jick H
Contraception; 1999 Feb; 59(2):79-83. PubMed ID: 10361621
[TBL] [Abstract][Full Text] [Related]
14. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
Potts M; Denny C
Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
[TBL] [Abstract][Full Text] [Related]
15. Third-generation oral contraceptives: how risky?
Weiss N
Lancet; 1995 Dec; 346(8990):1570. PubMed ID: 7500743
[TBL] [Abstract][Full Text] [Related]
16. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.
van Lunsen HW
Eur J Contracept Reprod Health Care; 1996; 1(1):39-45. PubMed ID: 9678136
[TBL] [Abstract][Full Text] [Related]
17. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
de Vries CS; van den Berg PB; de Jong-van den Berg LT
Contraception; 1998 Apr; 57(4):247-9. PubMed ID: 9649916
[TBL] [Abstract][Full Text] [Related]
19. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
